Nevada-based First Warning Systems have developed a non-invasive breast screening bra based on disruptive technology and tissue health science. The sports bra has a buit-in sensor which measures and records cell temperature changes associated with blood vessel growth that feeds tumors. Pattern recognition software is then used to analyze the data in order to help identify changes that could indicate a developing tumor.
This technology is not only more cost effective than mammography, it’s actually more accurate. According to First Warning Systems “Three preliminary clinical studies in more than 650 women have been completed yielding compelling results, demonstrating an average accuracy of 92.1% (percentage of correct classification), an average sensitivity of 94.7% (true positive cases), and an average specificity of 91.1% (true negative cases). In comparison, the specificity and sensitivity of the gold standard mammogram averages 70% and the accuracy of interpretation is completely subject to the skill and ability of the reading radiologist.”
First Warning Systems aim to have the bra available to European markets next year and pending regulatory approval in the United States by 2014.